Abstract
This study aimed to investigate the effect of serum albumin at admission, measured within 24 h after stroke onset, on the functional outcome in ischaemic stroke patients. The medical records of 76 first-ever hemiplegic ischaemic stroke patients were reviewed. Collected data included age, sex, initial stroke severity, cerebrovascular risk factors, lesion-related variables, aetiologic subtype of stroke and serum albumin at admission. The functional outcome was measured by functional independence measure (FIM) and modified Barthel index (MBI). Serum albumin at admission and initial National Institutes of Health Stroke Scale (NIHSS) score were correlated with the functional outcome, respectively. Serum albumin at admission was an independent predictor of MBI gain on multiple regression analysis. Serum albumin at admission would be a useful predictor of the functional outcome and trials for the correction of hypoalbuminaemia from the acute stage would be helpful to decrease the risk of poor outcome in ischaemic stroke patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dziedzic T, Slowik A, Szczudlik A (2004) Serum albumin level as a predictor of ischemic stroke outcome. Stroke 35:156–158
Dávalos A, Ricart W, Gonzalez-Huix F et al (1996) Effect of malnutrition after acute stroke on clinical outcome. Stroke 27:1028–1032
Franch-Arcas G (2001) The meaning of hypoalbuminemia in clinical practice. Clin Nutr 20:265–269
Belayev L, Pinard E, Nallet H et al (2002) Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke 33:1077–1084
Belayev L, Liu Y, Zhao W et al (2001) Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 32:553–560
Baker JP, Detsky AS, Wesson DE et al (1982) Nutritional assessment. N Engl J Med 306:969–972
Davis JP, Wong AA, Schluter PJ et al (2004) Impact of premorbid undernutrition on outcome in stroke patients. Stroke 35:1930–1934
Jongbloed L (1986) Prediction of function after stroke: a critical review. Stroke 17:765–775
Phillips A, Shaper AG, Whincup PH (1989) Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2:1434–1436
Aptaker RL, Roth EJ, Reichhardt G et al (1994) Serum albumin level as a predictor of geriatric stroke rehabilitation outcome. Arch Phys Med Rehabil 75:80–84
Reinhart WH, Nagy C (1995) Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest 25:523–528
Halliwell B (1998) Albumin - an important extracellular antioxidant? Biochem Pharmocol 37:569–571
Hallenbeck JM, Dutka AJ, Tanishima T et al (1986) Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17:246–253
Belayev L, Busto R, Zhao W et al (1997) Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. J Neurosurg 87:595–601
Palesch YY, Hill MD, Ryckborst KJ et al (2006) The ALIAS pilot trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke-II: neurologic outcome and efficacy analysis. Stroke 37:2107–2114
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, YM., Choi, IS., Bian, RX. et al. Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients. Neurol Sci 29, 445–449 (2008). https://doi.org/10.1007/s10072-008-1024-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-1024-0